Literature DB >> 33022361

Characterization of primary mouse hepatocyte spheroids as a model system to support investigations of drug-induced liver injury.

Manisha Nautiyal1, Rani J Qasem2, John K Fallon3, Kristina K Wolf4, Jingli Liu5, Darlene Dixon6, Philip C Smith7, Merrie Mosedale8.   

Abstract

Primary mouse hepatocytes isolated from genetically defined and/or diverse lines and disease models are a valuable resource for studying the impact of genetic and environmental factors on drug response and disease. However, standard monolayer cultures result in a rapid decline in mouse hepatocyte viability and functionality. Therefore, we evaluated 3D spheroid methodology for long-term culture of primary mouse hepatocytes, initially to support investigations of drug-induced liver injury (DILI). Primary hepatocytes isolated from male and female C57BL/6J mice were used to generate spheroids by spontaneous self-aggregation in ultra-low attachment plates. Spheroids with well-defined perimeters were observed within 5 days after seeding and retained morphology, ATP, and albumin levels for an additional 2 weeks in culture. Global microarray profiling and quantitative targeted proteomics assessing 10 important drug metabolizing enzymes and transporters demonstrated maintenance of mRNA and protein levels in spheroids over time. Activities for 5 major P450 enzymes were also stable and comparable to activities previously reported for human hepatocyte spheroids. Time- and concentration-dependent decreases in ATP and albumin were observed in response to the DILI-causing drugs acetaminophen, fialuridine, AMG-009, and tolvaptan. Collectively, our results demonstrate successful long-term culture of mouse hepatocytes as spheroids and their utility to support investigations of DILI.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  3D spheroids; Drug-induced liver injury; Gene expression; Primary mouse hepatocytes; Quantitative targeted absolute proteomics

Mesh:

Substances:

Year:  2020        PMID: 33022361      PMCID: PMC7736539          DOI: 10.1016/j.tiv.2020.105010

Source DB:  PubMed          Journal:  Toxicol In Vitro        ISSN: 0887-2333            Impact factor:   3.500


  47 in total

1.  Three-Dimensional (3D) HepaRG Spheroid Model With Physiologically Relevant Xenobiotic Metabolism Competence and Hepatocyte Functionality for Liver Toxicity Screening.

Authors:  Sreenivasa C Ramaiahgari; Suramya Waidyanatha; Darlene Dixon; Michael J DeVito; Richard S Paules; Stephen S Ferguson
Journal:  Toxicol Sci       Date:  2017-11-01       Impact factor: 4.849

2.  Reversibility of Liver Fibrosis and Inactivation of Fibrogenic Myofibroblasts.

Authors:  Xiao Liu; Jun Xu; David A Brenner; Tatiana Kisseleva
Journal:  Curr Pathobiol Rep       Date:  2013-09

3.  Transient Changes in Hepatic Physiology That Alter Bilirubin and Bile Acid Transport May Explain Elevations in Liver Chemistries Observed in Clinical Trials of GGF2 (Cimaglermin Alfa).

Authors:  Merrie Mosedale; Donald Button; Jonathan P Jackson; Kimberly M Freeman; Kenneth R Brouwer; Anthony O Caggiano; Andrew Eisen; Jennifer F Iaci; Tom J Parry; Ric Stanulis; Maya Srinivas; Paul B Watkins
Journal:  Toxicol Sci       Date:  2018-02-01       Impact factor: 4.849

4.  Generation of mice transgenic for human CYP2C18 and CYP2C19: characterization of the sexually dimorphic gene and enzyme expression.

Authors:  Susanne Löfgren; R Michael Baldwin; Masahiro Hiratsuka; Annelie Lindqvist; Anne Carlberg; Sarah C Sim; Meint Schülke; Michael Snait; Anne Edenro; Ronny Fransson-Steen; Ylva Terelius; Magnus Ingelman-Sundberg
Journal:  Drug Metab Dispos       Date:  2008-02-14       Impact factor: 3.922

5.  Sensitive and specific radioimmunoassay for fialuridine: initial assessment of pharmacokinetics after single oral doses to healthy volunteers.

Authors:  R R Bowsher; J A Compton; J A Kirkwood; G D Place; C D Jones; T E Mabry; D L Hyslop; B L Hatcher; K A DeSante
Journal:  Antimicrob Agents Chemother       Date:  1994-09       Impact factor: 5.191

6.  Sex differences in the circadian variation of cytochrome p450 genes and corresponding nuclear receptors in mouse liver.

Authors:  Yuan-Fu Lu; Tao Jin; Yasha Xu; Dan Zhang; Qin Wu; Yu-Kun Jennifer Zhang; Jie Liu
Journal:  Chronobiol Int       Date:  2013-08-08       Impact factor: 2.877

7.  From in vivo to in vitro: Major metabolic alterations take place in hepatocytes during and following isolation.

Authors:  Shamir Cassim; Valérie-Ann Raymond; Pascal Lapierre; Marc Bilodeau
Journal:  PLoS One       Date:  2017-12-28       Impact factor: 3.240

8.  Comparison of Hepatic 2D Sandwich Cultures and 3D Spheroids for Long-term Toxicity Applications: A Multicenter Study.

Authors:  Catherine C Bell; Anita C A Dankers; Volker M Lauschke; Rowena Sison-Young; Roz Jenkins; Cliff Rowe; Chris E Goldring; Kevin Park; Sophie L Regan; Tracy Walker; Chris Schofield; Audrey Baze; Alison J Foster; Dominic P Williams; Amy W M van de Ven; Frank Jacobs; Jos van Houdt; Tuula Lähteenmäki; Jan Snoeys; Satu Juhila; Lysiane Richert; Magnus Ingelman-Sundberg
Journal:  Toxicol Sci       Date:  2018-04-01       Impact factor: 4.849

Review 9.  Key Challenges and Opportunities Associated with the Use of In Vitro Models to Detect Human DILI: Integrated Risk Assessment and Mitigation Plans.

Authors:  Franck A Atienzar; Eric A Blomme; Minjun Chen; Philip Hewitt; J Gerry Kenna; Gilles Labbe; Frederic Moulin; Francois Pognan; Adrian B Roth; Laura Suter-Dick; Okechukwu Ukairo; Richard J Weaver; Yvonne Will; Donna M Dambach
Journal:  Biomed Res Int       Date:  2016-09-05       Impact factor: 3.411

Review 10.  Is It Time to Start Transitioning From 2D to 3D Cell Culture?

Authors:  Caleb Jensen; Yong Teng
Journal:  Front Mol Biosci       Date:  2020-03-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.